HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
4- (3- (bis(beta- hydroxyphenethyl)amino)butyl)benzamide
structure given in first source; RN given is for parent cpd
Also Known As:
Ro 16-8714; Ro-16-8714; maleate of Ro 16-8714
Networked:
3
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Amines: 4871
Biogenic Amines: 992
Biogenic Monoamines: 29
2-Hydroxyphenethylamine: 1
4-(3-(bis(beta-hydroxyphenethyl)amino)butyl)benzamide: 3
Amino Alcohols: 20
Ethanolamines: 16
2-Hydroxyphenethylamine: 1
4-(3-(bis(beta-hydroxyphenethyl)amino)butyl)benzamide: 3
Ethylamines: 5
Phenethylamines: 28
2-Hydroxyphenethylamine: 1
4-(3-(bis(beta-hydroxyphenethyl)amino)butyl)benzamide: 3
Alcohols: 595
Amino Alcohols: 20
Ethanolamines: 16
2-Hydroxyphenethylamine: 1
4-(3-(bis(beta-hydroxyphenethyl)amino)butyl)benzamide: 3
Related Diseases
1.
Tachycardia (Tachyarrhythmias)
01/01/1987 - "
It is concluded that in lean individuals Ro 16-8714 is a potent thermogenic agent; however, new beta-adrenoceptor agonists should be developed in order to avoid the tachycardia associated with the thermogenic effect.
"
2.
Obesity
01/01/1984 - "
p-[(R)-3-[bis-[(R)-beta-hydroxyphenethyl]amino]butyl]benzamide (Ro 16-8714/000) is one of the most effective compounds, of a new series of calorigenic bis-phenethanolamine derivatives, which combine anti-obesity and antidiabetic qualities.
"
3.
Hyperglycemia
02/01/1992 - "
Treatment with a beta-agonist, Ro 16-8714, decreases the glycosuria, hyperglycemia, hyperketonemia, and hepatic glucose production.
"
4.
Glycosuria
02/01/1992 - "
Treatment with a beta-agonist, Ro 16-8714, decreases the glycosuria, hyperglycemia, hyperketonemia, and hepatic glucose production.
"
Related Drugs and Biologics
1.
Adrenergic Receptors (Adrenergic Receptor)
2.
Hypoglycemic Agents (Hypoglycemics)
3.
Glucose (Dextrose)
4.
benzamide